압력/접촉 활성식 안전 란셋 시장 : 규모, 점유율, 성장, 산업 분석, 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of pressure/contact-activated safety lancet Market

The global pressure/contact-activated safety lancet market was valued at USD 456.23 million in 2025 and is projected to grow to USD 502.67 million in 2026, reaching USD 1,164.18 million by 2034, representing a CAGR of 11.07% during the forecast period. North America dominated the market in 2025 with a 42.37% share, equivalent to USD 193.32 million, driven by strong demand for advanced devices and significant reimbursement for chronic disease monitoring products.

Pressure/contact-activated safety lancets are single-use, disposable devices used for capillary blood sampling in diabetes management and diagnostic applications. They feature automatic retraction and are activated when slight pressure is applied on the fingertip. Their ease of use, limited pain, and minimal blood loss are key factors driving adoption in hospitals, clinics, and home healthcare settings.

Market Dynamics

Drivers

The rising prevalence of diabetes globally is a major market driver. Frequent blood glucose monitoring is required for effective diabetes management, fueling the demand for safety lancets. Pressure-activated lancets offer consistent penetration depth, reduced risk of needlestick injuries, and convenience for self-monitoring at home. According to the International Diabetes Federation (July 2025), 589 million adults lived with diabetes globally in 2024, a number projected to reach 853 million by 2050, highlighting the sustained need for lancets.

Increasing awareness about safe diabetes care and adoption of minimally invasive technologies further drives market growth across hospitals, clinics, and home care.

Restraints

The market faces competition from button-activated lancets, which provide more predictable depth penetration and ergonomic designs. Innovations such as multi-depth adjustment and quieter mechanisms have increased their adoption, particularly among elderly or neuropathic patients, limiting the market growth of pressure/contact-activated devices.

Opportunities

The shift toward home healthcare monitoring offers lucrative opportunities. Self-monitoring of blood glucose is increasing due to the need for cost-effective and convenient care. Contact-activated lancets, eliminating the need for activation buttons, are ideal for untrained users, including elderly and pediatric patients. For instance, a 2023 study reported that 35% of patients in India self-monitored blood glucose at home using glucometers, demonstrating rising demand for at-home diagnostic tools.

Challenges

Limited accessibility and affordability in low- and middle-income countries restrict market expansion. Countries with less-developed healthcare infrastructure, such as Bangladesh, spend as little as 2.34% of GDP on public healthcare, limiting adoption. Awareness gaps and hesitation among manufacturers to enter these regions also pose growth challenges.

Market Trends

Integration of ultra-fine gauge technology and ergonomic designs is a key trend. Lancets with 21G-30G ultra-thin needles and spring-loaded mechanisms provide nearly painless sampling. Sustainability-focused designs using biodegradable components are emerging to reduce environmental impact, while regulatory standards continue to favor safety-engineered sharps in clinical settings.

Segmentation Analysis

By Incision Type: Needle lancets dominate due to safety, less pain, and ease of use. Blade lancets are also growing, especially for neonatal and multi-test applications.

By Age Group: Adults dominate adoption, driven by HbA1c, cholesterol, and coagulation testing, while pediatric usage is increasing among Type 1 diabetes patients.

By Application: Blood glucose monitoring leads the market, driven by self-monitoring trends, followed by hemoglobin testing, which is growing rapidly due to HBA1C testing demand.

By Gauge Size: Lancets above 28G dominate for minimal trauma and small blood volume needs. 22G and below are used in clinical labs requiring higher sample yields.

By Distribution Channel: Hospital pharmacies lead in 2025, while online pharmacies are expected to register the highest CAGR due to convenience and growing e-commerce penetration.

Regional Outlook

• North America: USD 193.32 million in 2025; strong demand and reimbursement support growth.
• Europe: Second-largest market due to high spending on diabetes monitoring devices. NHS spending on lancets reached USD 13.4 million in 2020.
• Asia Pacific: Fastest-growing region due to highest diabetes prevalence; India and China are key contributors.
• Latin America & Middle East/Africa: Smaller shares, but rising awareness and healthcare spending are supporting growth.

Competitive Landscape

The market is moderately consolidated. Leading players include BD, HTL-STREFA, Cardinal Health, Medline Industries, Braun SE, Aeras Medical, and Owen Mumford. Strategic initiatives such as new product launches, geographic expansion, and promotional activities at conferences strengthen their market position.

Key Developments:

• April 2025: SteriLance showcased lancets at CMEF Spring 2025.
• January 2025: BD expanded U.S. manufacturing for lancets.
• November 2024: Sterilance participated in MEDICA 2024 to highlight innovative devices.

Conclusion

The global pressure/contact-activated safety lancet market, valued at USD 456.23 million in 2025, is projected to grow to USD 502.67 million in 2026 and reach USD 1,164.18 million by 2034 at a CAGR of 11.07%. Growth is driven by rising diabetes prevalence, demand for self-monitoring, adoption of ultra-fine gauge and ergonomic designs, and expanding home healthcare trends. While competition from button-activated lancets and limited accessibility in low-income regions pose challenges, technological innovation, increasing home diagnostics, and favorable reimbursement policies are expected to sustain market expansion through 2034.

Segmentation By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Region

By Incision Type * Needle

• Blade

By Age Group * Adult

• Pediatric

By Application * Blood Glucose Monitoring

• Hemoglobin Testing
• Cholesterol Testing
• Others

By Gauge Size * 22G and Below

• 23G-28G
• Above 28G

By Distribution Channel * Hospital Pharmacies

• Retail Pharmacies
• Online Pharmacies/E-commerce Platforms

By Region * North America (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Country)

• U.S.
• Canada
• Europe (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, Country/Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Diabetes - by Key Countries/Regions, 2025
• 4.2. Estimated Number of SMBG Users, By Key Countries/Region, 2025
• 4.3. Reimbursements Scenario
• 4.4. Pricing Analysis
• 4.5. Key Industry Developments (Mergers, Acquisitions, Partnership; etc.)

5. Global Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Incision Type
  • 5.1.1. Needle
  • 5.1.2. Blade
• 5.2. Market Analysis, Insights and Forecast - By Age Group
  • 5.2.1. Adult
  • 5.2.2. Pediatric
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Blood Glucose Monitoring
  • 5.3.2. Hemoglobin Testing
  • 5.3.3. Cholesterol Testing
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 5.4.1. 22G and Below
  • 5.4.2. 23G-28G
  • 5.4.3. Above 28G
• 5.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 5.5.1. Hospital Pharmacies
  • 5.5.2. Retail Pharmacies
  • 5.5.3. Online Pharmacies/E-commerce Platforms
• 5.6. Market Analysis, Insights and Forecast - By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Latin America
  • 5.6.5. Middle East & Africa

6. North America Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Incision Type
  • 6.1.1. Needle
  • 6.1.2. Blade
• 6.2. Market Analysis, Insights and Forecast - By Age Group
  • 6.2.1. Adult
  • 6.2.2. Pediatric
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Blood Glucose Monitoring
  • 6.3.2. Hemoglobin Testing
  • 6.3.3. Cholesterol Testing
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 6.4.1. 22G and Below
  • 6.4.2. 23G-28G
  • 6.4.3. Above 28G
• 6.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 6.5.1. Hospital Pharmacies
  • 6.5.2. Retail Pharmacies
  • 6.5.3. Online Pharmacies/E-commerce Platforms
• 6.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 6.6.1. U.S.
  • 6.6.2. Canada

7. Europe Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Incision Type
  • 7.1.1. Needle
  • 7.1.2. Blade
• 7.2. Market Analysis, Insights and Forecast - By Age Group
  • 7.2.1. Adult
  • 7.2.2. Pediatric
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Blood Glucose Monitoring
  • 7.3.2. Hemoglobin Testing
  • 7.3.3. Cholesterol Testing
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 7.4.1. 22G and Below
  • 7.4.2. 23G-28G
  • 7.4.3. Above 28G
• 7.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 7.5.1. Hospital Pharmacies
  • 7.5.2. Retail Pharmacies
  • 7.5.3. Online Pharmacies/E-commerce Platforms
• 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.6.1. U.K.
  • 7.6.2. Germany
  • 7.6.3. France
  • 7.6.4. Spain
  • 7.6.5. Italy
  • 7.6.6. Scandinavia
  • 7.6.7. Rest of Europe

8. Asia pacific Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Incision Type
  • 8.1.1. Needle
  • 8.1.2. Blade
• 8.2. Market Analysis, Insights and Forecast - By Age Group
  • 8.2.1. Adult
  • 8.2.2. Pediatric
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Blood Glucose Monitoring
  • 8.3.2. Hemoglobin Testing
  • 8.3.3. Cholesterol Testing
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 8.4.1. 22G and Below
  • 8.4.2. 23G-28G
  • 8.4.3. Above 28G
• 8.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 8.5.1. Hospital Pharmacies
  • 8.5.2. Retail Pharmacies
  • 8.5.3. Online Pharmacies/E-commerce Platforms
• 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. Australia
  • 8.6.5. Southeast Asia
  • 8.6.6. Rest of Asia Pacific

9. Latin America Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Incision Type
  • 9.1.1. Needle
  • 9.1.2. Blade
• 9.2. Market Analysis, Insights and Forecast - By Age Group
  • 9.2.1. Adult
  • 9.2.2. Pediatric
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Blood Glucose Monitoring
  • 9.3.2. Hemoglobin Testing
  • 9.3.3. Cholesterol Testing
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 9.4.1. 22G and Below
  • 9.4.2. 23G-28G
  • 9.4.3. Above 28G
• 9.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 9.5.1. Hospital Pharmacies
  • 9.5.2. Retail Pharmacies
  • 9.5.3. Online Pharmacies/E-commerce Platforms
• 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.6.1. Brazil
  • 9.6.2. Mexico
  • 9.6.3. Rest of Latin America

10. Middle East & Africa Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Incision Type
  • 10.1.1. Needle
  • 10.1.2. Blade
• 10.2. Market Analysis, Insights and Forecast - By Age Group
  • 10.2.1. Adult
  • 10.2.2. Pediatric
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Blood Glucose Monitoring
  • 10.3.2. Hemoglobin Testing
  • 10.3.3. Cholesterol Testing
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 10.4.1. 22G and Below
  • 10.4.2. 23G-28G
  • 10.4.3. Above 28G
• 10.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 10.5.1. Hospital Pharmacies
  • 10.5.2. Retail Pharmacies
  • 10.5.3. Online Pharmacies/E-commerce Platforms
• 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.6.1. GCC
  • 10.6.2. South Africa
  • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  • 11.2.1. B. Braun SE
  • 11.2.2. Cardinal Health
  • 11.2.3. Greiner Bio-One International GmbH
  • 11.2.4. BD
  • 11.2.5. HTL-STREFA (MTD Medical Technology and Devices)
  • 11.2.6. Medline Industries, LP.
  • 11.2.7. Aeras Medical Pte Ltd.
  • 11.2.8. Owen Mumford